|
URGN Urogen Pharma Ltd 1668243 |
| Balance Sheet |
|
Current Assets
|
$237,464,000.00 |
|
Assets
|
$253,690,000.00 |
|
Current Liabilities
|
$50,635,000.00 |
|
Liabilities
|
$377,943,000.00 |
|
Equity
|
$-124,253,000.00 |
|
Shares Out
|
48708280.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-45,316,000.00 |
|
Investing Cash Flow
|
$-20,688,000.00 |
| Market Analysis |
Market Cap
|
$2,001,423,225.20 |
|
Price
|
$37.04 |
|
PB
|
5.22 |
|
EPS
|
-0.47 |
|
PS
|
9.09 |
|
FCF
|
$-45,370,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.54 |
|
|
2026-05-06 |
-0.47 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.05 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.69 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view URGN documents filed with the SEC.
URGN Filings
Clear
